Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study.

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: WFRF:(Wielgosz Andreas) > (2023) > Associations of Ant...

1 av 1
Föregående post
Nästa post
Till träfflistan

LIBRIS Formathandbok (Information om MARC21)

Fältnamn	Indikatorer	Metadata
000		05598naa a2201021 4500
001		oai:gup.ub.gu.se/328863
003		SwePub
008		240910s2023 \| \|\|\|\|\|\|\|\|\|\|\|000 \|\|eng\|
009		oai:prod.swepub.kib.ki.se:153741466
024	7	a https://gup.ub.gu.se/publication/3288632 URI
024	7	a https://doi.org/10.1016/j.cgh.2022.11.0372 DOI
024	7	a http://kipublications.ki.se/Default.aspx?queryparsed=id:1537414662 URI
040		a (SwePub)gud (SwePub)ki
041		a eng
042		9 SwePub
072	7	a ref2 swepub-contenttype
072	7	a art2 swepub-publicationtype
100	1	a Narula, Neeraj4 aut
245	1 0	a Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study.
264	1	b Elsevier BV,c 2023
520		a Several medications have been suspected to contribute to the etiology of inflammatory bowel disease (IBD). This study assessed the association between medication use and the risk of developing IBD using the Prospective Urban Rural Epidemiology cohort.This was a prospective cohort study of 133,137 individuals between the ages of 20 and 80 from 24 countries. Country-specific validated questionnaires documented baseline and follow-up medication use. Participants were followed up prospectively at least every 3 years. The main outcome was the development of IBD, including Crohn's disease (CD) and ulcerative colitis (UC). Short-term (baseline but not follow-up use) and long-term use (baseline and subsequent follow-up use) were evaluated. Results are presented as adjusted odds ratios (aORs) with 95% CIs.During a median follow-up period of 11.0 years (interquartile range, 9.2-12.2 y), there were 571 incident IBD cases (143 CD and 428 UC). Incident IBD was associated significantly with baseline antibiotic (aOR, 2.81; 95% CI, 1.67-4.73; P= .0001) and hormonal medication use (aOR, 4.43; 95% CI, 1.78-11.01; P= .001). Among females, previous or current oral contraceptive use also was associated with IBD development (aOR, 2.17; 95% CI, 1.70-2.77; P < .001). Nonsteroidal anti-inflammatory drug users also were observed to have increased odds of IBD (aOR, 1.80; 95% CI, 1.23-2.64; P= .002), which was driven by long-term use (aOR, 5.58; 95% CI, 2.26-13.80; P < .001). All significant results were consistent in direction for CD and UC with low heterogeneity.Antibiotics, hormonal medications, oral contraceptives, and long-term nonsteroidal anti-inflammatory drug use were associated with increased odds of incident IBD after adjustment for covariates.
650	7	a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicin0 (SwePub)3022 hsv//swe
650	7	a MEDICAL AND HEALTH SCIENCESx Clinical Medicine0 (SwePub)3022 hsv//eng
653		a Female
653		a Humans
653		a Young Adult
653		a Adult
653		a Middle Aged
653		a Aged
653		a Aged
653		a 80 and over
653		a Contraceptives
653		a Oral
653		a Prospective Studies
653		a Anti-Inflammatory Agents
653		a Non-Steroidal
653		a adverse effects
653		a Anti-Bacterial Agents
653		a adverse effects
653		a Risk Factors
653		a Inflammatory Bowel Diseases
653		a drug therapy
653		a epidemiology
653		a Colitis
653		a Ulcerative
653		a drug therapy
653		a Crohn Disease
653		a drug therapy
653		a Surveys and Questionnaires
700	1	a Wong, Emily C L4 aut
700	1	a Pray, Cara4 aut
700	1	a Marshall, John K4 aut
700	1	a Rangarajan, Sumathy4 aut
700	1	a Islam, Shofiqul4 aut
700	1	a Bahonar, Ahmad4 aut
700	1	a Alhabib, Khalid F4 aut
700	1	a Kontsevaya, Anna4 aut
700	1	a Ariffin, Farnaza4 aut
700	1	a Co, Homer U4 aut
700	1	a Al Sharief, Wadeia4 aut
700	1	a Szuba, Andrzej4 aut
700	1	a Wielgosz, Andreas4 aut
700	1	a Diaz, Maria Luz4 aut
700	1	a Yusuf, Rita4 aut
700	1	a Kruger, Lanthé4 aut
700	1	a Soman, Biju4 aut
700	1	a Li, Yang4 aut
700	1	a Wang, Chuangshi4 aut
700	1	a Yin, Luu Karolinska Institutet4 aut
700	1	a Mirrakhimov, Erkin4 aut
700	1	a Lanas, Fernando4 aut
700	1	a Davletov, Kairat4 aut
700	1	a Rosengren, Annika,d 1951u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xrosan
700	1	a Lopez-Jaramillo, Patricio4 aut
700	1	a Khatib, Rasha4 aut
700	1	a Oguz, Aytekin4 aut
700	1	a Iqbal, Romaina4 aut
700	1	a Yeates, Karen4 aut
700	1	a Avezum, Álvaro4 aut
700	1	a Reinisch, Walter4 aut
700	1	a Moayyedi, Paul4 aut
700	1	a Yusuf, Salim4 aut
710	2	a Karolinska Institutetb Institutionen för medicin, avdelningen för molekylär och klinisk medicin4 org
773	0	t Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Associationd : Elsevier BVg 21:10q 21:10x 1542-7714
773	0	t Clinical Gastroenterology and Hepatologyd : Elsevier BVg 21:10q 21:10x 1542-3565
856	4 8	u https://gup.ub.gu.se/publication/328863
856	4 8	u https://doi.org/10.1016/j.cgh.2022.11.037
856	4 8	u http://kipublications.ki.se/Default.aspx?queryparsed=id:153741466

Hitta via bibliotek

Clinical gastroenterology and hepatology : the official clinical practice journa... (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

1 av 1
Föregående post
Nästa post
Till träfflistan

Hitta mer i SwePub

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Klinisk medicin

Artiklar i publikationen: Clinical gastroe ...; Clinical Gastroe ...

Av lärosätet: Göteborgs universitet; Karolinska Institutet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se